ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756053; 2) Community: the network communities that were significantly associated with the response to NSC 756053; 3) Molecule: the relationships between components within communities and NSC 756053; 4) MDR: the compounds that were significantly associated with the NSC 756053.

NSC Compound Enrichment Correlation
NSC 52426 Null 0.0385613993886001 -0.13756163
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0385613993886001 -0.26787806
NSC 606497 Camptothecin Derivative 0.0385613993886001 -0.21275105
NSC 606499 Camptothecin Derivative 0.0385613993886001 -0.20884952
NSC 625731 Null 0.0385613993886001 -0.15209027
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.0385613993886001 0.38492196
NSC 638279 Null 0.0385613993886001 -0.15910737
NSC 63878 Cytarabine Hydrochloride AZ 0.0385613993886001 -0.24613334
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0385613993886001 -0.42628771
NSC 644651 Null 0.0385613993886001 -0.4060454
Total:76  Current:51    [First] [Prev] [Next] [Last]